Experience

University of Western Australia v. Academisch Ziekenhuis Leiden

Sarepta Therapeutics

Academisch Ziekenhuis Leiden

Successfully represented University of Western Australia in interferences involving eteplirsen.

Sarepta Therapeutics v. Academisch Ziekenhuis Leiden, 106,007, 106,008, 106,013, PTAB

Related Professionals

William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Ryan P. O'Quinn, Ph.D.
Partner
Reston, VA
+1 571 203 2426
Email

Related Practices

Patent Office Invalidation Proceedings

Interferences

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Academisch Ziekenhuis Leiden v. University of Western Australia

University of Western Australia

Academisch Ziekenhuis Leiden v. University of Western Australia

University of Western Australia

Clear skies ahead for drone maker DJI after defeating NPE at the PTAB and in the Western District of Texas

SZ DJI Technology Co., Ltd.

Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

Nanosys, Inc. v. The Board of Trustees of the University of Arkansas et al.

The Board of Trustees of the University of Arkansas et al.

Orbital Australia Pty. Ltd. et al. v. Daimler AG, Mercedes-Benz USA, LLC, Mercedes-Benz US International, Inc., Robert Bosch GmbH, and Robert Bosch LLC

Robert Bosch GmbH et al.

Defeating a motion for preliminary injunction in the Western District of Texas

Cosentino SA et al

SAP prevails in first PTAB post-grant review decision

SAP America Inc.

Rare PTAB rehearing request granted for Finnegan client Incyte

Incyte Corp.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.